Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Meihua International Medical Technologies Co Ltd (MHUA)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/15/2025: MHUA (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -61.68% | Avg. Invested days 26 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/15/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 14.36M USD | Price to earnings Ratio 1.13 | 1Y Target Price - |
Price to earnings Ratio 1.13 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.85 | 52 Weeks Range 0.25 - 1.47 | Updated Date 06/29/2025 |
52 Weeks Range 0.25 - 1.47 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.4 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 11.19% | Operating Margin (TTM) 16.33% |
Management Effectiveness
Return on Assets (TTM) 5% | Return on Equity (TTM) 7.09% |
Valuation
Trailing PE 1.13 | Forward PE - | Enterprise Value 6349300 | Price to Sales(TTM) 0.15 |
Enterprise Value 6349300 | Price to Sales(TTM) 0.15 | ||
Enterprise Value to Revenue 0.07 | Enterprise Value to EBITDA 0.4 | Shares Outstanding 31904500 | Shares Floating 15734833 |
Shares Outstanding 31904500 | Shares Floating 15734833 | ||
Percent Insiders 49.95 | Percent Institutions 1.06 |
Upturn AI SWOT
Meihua International Medical Technologies Co Ltd
Company Overview
History and Background
Meihua International Medical Technologies Co Ltd. (MHUA) is a medical device company. The specific founding year and detailed early milestones are difficult to find in readily available financial databases and the company website.
Core Business Areas
- Medical Device Manufacturing: The company primarily manufactures and sells a variety of disposable medical devices used in hospitals and other healthcare facilities. Their product line includes various types of tubes, bags, and sets that are commonly used in medical procedures.
Leadership and Structure
Specific details about the leadership team and organizational structure are not readily available in standard financial data sources.
Top Products and Market Share
Key Offerings
- Disposable Medical Devices (Tubes, Bags, Sets): Meihua manufactures and sells disposable medical devices such as infusion sets, blood transfusion sets, urine bags, and other related products. Exact market share is hard to determine as they operate in a niche area, and market data specific to their product lines is limited. Competitors include larger medical supply companies that offer similar disposable products. Companies such as Cardinal Health (CAH), Medline, and BD (BDX) are competitors.
Market Dynamics
Industry Overview
The medical device industry is large and growing, driven by an aging population, increasing healthcare spending, and technological advancements. The disposable medical device segment is influenced by infection control concerns and the need for convenient, single-use products.
Positioning
Meihua likely positions itself as a cost-effective manufacturer of disposable medical devices, catering to hospitals and healthcare providers seeking affordable solutions. Competitive advantages might include manufacturing efficiency and established relationships with distributors.
Total Addressable Market (TAM)
The global disposable medical supplies market is estimated to be in the billions of dollars. Meihua's positioning within this TAM is likely focused on specific product categories and geographic regions, suggesting a smaller but targeted market share.
Upturn SWOT Analysis
Strengths
- Manufacturing expertise in disposable medical devices
- Potential for cost-effective production
- Established relationships with distributors (assumed)
Weaknesses
- Limited brand recognition compared to larger competitors
- Dependence on specific product lines
- Potential vulnerability to pricing pressures
Opportunities
- Expansion into new geographic markets
- Development of innovative disposable medical devices
- Strategic partnerships with healthcare providers
Threats
- Increased competition from established players
- Changing regulations and standards in the medical device industry
- Fluctuations in raw material prices
Competitors and Market Share
Key Competitors
- CAH
- BDX
- MDT
Competitive Landscape
Meihua faces stiff competition from larger, more established medical device companies. Its success depends on its ability to offer competitive pricing, maintain product quality, and expand its market reach.
Growth Trajectory and Initiatives
Historical Growth: Not available
Future Projections: Not available
Recent Initiatives: Not available
Summary
Meihua International Medical Technologies Co Ltd. is a manufacturer of disposable medical devices. While they likely offer cost-effective solutions, they face strong competition from larger players. Their success hinges on product innovation, market expansion, and strategic partnerships. Further, financial data and analyst rating need to be consulted via investment websites for more accurate details. This stock might be better if they could get better brand recognition
Peer Comparison
Sources and Disclaimers
Data Sources:
- SEC filings, company website, general financial news sources.
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Investment decisions should be based on thorough research and consultation with a financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Meihua International Medical Technologies Co Ltd
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2022-02-16 | CEO & Director Mr. Wang Xin | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 619 | Website https://www.meihuamed.com |
Full time employees 619 | Website https://www.meihuamed.com | ||
Meihua International Medical Technologies Co., Ltd. engages in the research and development, manufacture, and sale of medical devices in the People's Republic of China. The company offers Class I disposable medical devices, including disposable medical X-ray films, medical dry films, dry laser imagers, gauze bandages, examination gloves, pharmaceutical packaging materials and containers, low-density polyethylene bottles for eye drops, and high-density polyethylene bottles for tablets; Class II products, such as disposable full anesthesia kits, medical brush, woman's examination kits, urethral catheterization kits, gynecological examination kits, endotracheal intubation, medical masks, anal bags, and suction connecting tube, etc.; and Class III disposable medical devices, such as disposable infusion pumps, anesthesia puncture kits, electronic pumps, etc. It also offers disposable plastic baby bottles, NB/PSN rubber covers and 8.2mL folded spoons for tools and containers, etc.; Class II 6866 medical polymer materials and products, including transfusion equipment and pipelines, endotracheal intubation for respiratory anesthesia or ventilation; and medical x-ray films and multi-functional self-extracting X-ray film machines. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.